List of GENEius Adaptaion Software Customers
Louisville, 40299, KY,
United States
Since 2010, our global team of researchers has been studying GENEius Adaptaion Software customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased GENEius Adaptaion Software for Laboratory Management from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using GENEius Adaptaion Software for Laboratory Management include: North Carolina Central University, a United States based Education organisation with 1638 employees and revenues of $272.0 million, Tokyo University of Science, a Japan based Education organisation with 500 employees and revenues of $100.0 million, The Cyprus Institute of Neurology and Genetics, a Cyprus based Non Profit organisation with 200 employees and revenues of $30.0 million and many others.
Contact us if you need a completed and verified list of companies using GENEius Adaptaion Software, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The GENEius Adaptaion Software customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
North Carolina Central University | Education | 1638 | $272M | United States | Eurofins Genomics | GENEius Adaptaion Software | Laboratory Management | 2018 | n/a |
In 2018, North Carolina Central University engaged Eurofins Genomics services and is inferred to have used GENEius Adaptaion Software in a Laboratory Management capacity to support molecular biology research. Researchers in the Department of Pharmaceutical Sciences BRITE used Eurofins Genomics facilities in Huntsville and Louisville for primer and oligonucleotide synthesis and for plasmid sequencing to support cloning and minigene construction, as documented in the 2019 publication, and the presence of GENEius Adaptaion Software is inferred from Eurofins providing sequence verification and synthesis for that study.
Implementation scope centers on sequence adaptation and primer design workflows typical of Laboratory Management applications, aligning sequence verification outputs with synthesis ordering and sample submission processes used by BRITE research labs. Functionally, inferred use of GENEius Adaptaion Software would encompass sequence adaptation and verification capabilities that close the design to synthesis loop, integrating sequencing results and oligo synthesis provisioning into laboratory workflows and formalizing sequence acceptance checks for cloning and minigene construction.
|
 |
The Cyprus Institute of Neurology and Genetics | Non Profit | 200 | $30M | Cyprus | Eurofins Genomics | GENEius Adaptaion Software | Laboratory Management | 2017 | n/a |
In 2017, the Cyprus Institute of Neurology and Genetics implemented GENEius Adaptaion Software, a Laboratory Management application. Eurofins Genomics supplied chemically synthesized oligonucleotides used by institute researchers for SELEX and RNA aptamer experiments, supporting molecular biology laboratory workflows and peer reviewed publication outcomes described in subsequent literature.
Module usage of the GENEius Adaptaion Software is inferred from procurement of gene and oligo synthesis through Eurofins Genomics, consistent with Laboratory Management functionality such as codon optimization, sequence adaptation, and oligonucleotide design workflows. The implementation narrative indicates the GENEius Adaptaion Software was used to align sequence design with supplier synthesis constraints and to streamline ordering related to experimental protocols.
Operational coverage centered on molecular biology research groups at the Cyprus Institute of Neurology and Genetics in Nicosia, with the application embedded into experimental workflows for SELEX and RNA aptamer development. Adoption appears researcher led, integrating design and ordering steps into the laboratory execution path and experimental documentation used for peer reviewed publication.
The 2018 publication that documents the project supplies the explicit link between Eurofins Genomics synthesis orders and the institute experimental outcomes, which underpins the inference of GENEius Adaptaion Software usage for codon adaptation and sequence preparation. Governance details are described at the project level, with the software supporting lab level sequencing design and supplier coordination rather than enterprise wide administrative functions.
|
 |
Tokyo University of Science | Education | 500 | $100M | Japan | Eurofins Genomics | GENEius Adaptaion Software | Laboratory Management | 2019 | n/a |
In 2019, Tokyo University of Science is inferred to have used GENEius Adaptaion Software in Laboratory Management workflows supporting an evolutionary molecular biology research group. This inference is drawn from the research team's procurement of primers and RNA substrates through Eurofins Genomics K.K. Tokyo, and the 2020 publication that documents Eurofins sequence and oligonucleotide services for the experiments. The narrative treats GENEius Adaptaion Software as Eurofins' codon optimization and sequence adaptation tool linked to those synthesis services.
Module usage described or reasonably inferred centers on codon optimization and sequence adaptation capabilities, applied to primer and RNA substrate design and specification for external synthesis. Functional terminology consistent with Laboratory Management is reflected, including sequence input management, codon usage adjustment, oligonucleotide specification export, and assay preparation workflows used by bench researchers. Configuration work would focus on aligning sequence adaptation parameters with experimental design constraints and preparing standardized exports for synthesis suppliers.
Operational scope was limited to a specific research group at Tokyo University of Science, supporting biochemical and molecular assays reported in the cited study. Documented integrations are confined to the Eurofins Genomics K.K. relationship for synthesis and sequence services, representing a design to procurement handoff from GENEius Adaptaion Software modules to external synthesis fulfillment rather than internal instrument automation. Governance implications inferred include tighter sequence approval and experimental design review steps to control adapted sequences before external ordering and to coordinate laboratory workflows with the external provider.
|
Buyer Intent: Companies Evaluating GENEius Adaptaion Software
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||